日报更新时间：
周报更新时间：04-11 03:39
今开价：23.91
最高价：24.11
成交量：1720975.0
昨收价：23.95
最低价：23.39
最新价：23.59
中文名称：伊克力西斯
英文名称：Exelixis
行业：医疗
简介：Exelixis, Inc.是一家生物科技公司，致力于研发癌症小分子治疗
电话：1-650-8377000
Exelixis的产品包括： COMETRIQ——一种多重受体酪氨酸激酶抑制剂，用于转移性甲状腺髓样癌的治疗；此外，产品也被用于其他多种癌症的治疗临床试验（同时进行的临床试验达45个之多），主要集中在转移性肾细胞癌（MRCC）和进阶肝细胞癌（HCC） Cobimetinib——一种MEK抑制剂，目前处于关键的第三阶段临床试验，主要用于晚期转移性黑素瘤的初治患者。Exelixis, Inc.目前与行业内的几个大佬，如：Genentech，葛兰素史克，施贵宝公司，赛诺菲，默克公司和Daiichi Sankyo公司等都有合作，而且其抗癌产品业界普遍认为可以和JUNO媲美。
| 交易日期 | 交易人 | 职位 | 类型 | 交易份额 | 价格 |
|---|---|---|---|---|---|
| 2019-07-16 | Morrissey (Michael M) | Chief Executive Officer | Buy | 50000 | 7.18 |
| 2019-07-16 | Morrissey (Michael M) | Chief Executive Officer | Sell | 34721 | 21.37 |
| 2019-07-09 | Haley (Patrick Joseph) | Officer | Sell | 1000 | 20.96 |
| 2019-07-02 | Morrissey (Michael M) | Chief Executive Officer | Buy | 50000 | 7.18 |
| 2019-07-02 | Morrissey (Michael M) | Chief Executive Officer | Sell | 34721 | 21.03 |
| 2019-06-30 | Scangos (George A) | Director | Sell | 40000 | 21.58 |
| 2019-06-18 | LAMB PETER | Officer | Buy | 17404 | 5.51 |
| 2019-06-17 | LAMB PETER | Officer | Sell | 100000 | 20.67 |
| 2019-06-17 | LAMB PETER | Officer | Buy | 75404 | 1.70 |
| 2019-06-17 | LAMB PETER | Officer | Buy | 24596 | 5.51 |
| 2019-06-16 | LAMB PETER | Officer | Sell | 17404 | 20.76 |
| 2019-06-16 | LAMB PETER | Officer | Buy | 95404 | 5.56 |
| 2019-06-16 | LAMB PETER | Officer | Sell | 100000 | 20.49 |
| 2019-06-16 | LAMB PETER | Officer | Buy | 4596 | 1.70 |
| 2019-06-12 | LAMB PETER | Officer | Buy | 27596 | 5.56 |
| 2019-06-12 | LAMB PETER | Officer | Sell | 27596 | 20.03 |
| 2019-06-09 | Haley (Patrick Joseph) | Officer | Sell | 1000 | 20.23 |
| 2019-06-03 | Scangos (George A) | Director | Sell | 15000 | 20.00 |
| 2019-06-02 | Scangos (George A) | Director | Sell | 25000 | 19.61 |
| 2019-05-28 | Morrissey (Michael M) | Chief Executive Officer | Buy | 14591 | 7.18 |
| 2019-05-22 | Poste (George H) | Director | Buy | 10317 | -- |
| 2019-05-22 | Papadopoulos (Stelios B) | Director | Buy | 10317 | -- |
| 2019-05-22 | Marchesi (Vincent T) | Director | Buy | 10317 | -- |
| 2019-05-22 | Freire (Maria C) | Director | Buy | 10317 | -- |
| 2019-05-22 | Wyszomierski (Jack L) | Director | Buy | 10317 | -- |
| 机构持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| Bellevue Asset Management AG | 3472850 | 1.15% | 75250 | 2.21% | 2019-07-31 |
| Meditor Group Ltd | 15094495 | 5.00% | -871543 | -5.46% | 2019-03-31 |
| Meditor Capital Management Limited | 15094495 | 5.00% | -871543 | -5.46% | 2019-03-31 |
| AQR Capital Management LLC | 15852556 | 5.25% | 5021444 | 46.36% | 2019-03-31 |
| BlackRock Fund Advisors | 18627177 | 6.15% | 58933 | 0.32% | 2019-07-31 |
| Fidelity Management and Research Company | 20628896 | 6.84% | -679439 | -3.19% | 2019-03-31 |
| FMR Inc | 20639046 | 6.84% | -678843 | -3.18% | 2019-03-31 |
| Vanguard Group Inc | 27733773 | 9.19% | 398054 | 1.46% | 2019-03-31 |
| BlackRock Inc | 30875633 | 10.23% | 290882 | 0.95% | 2019-03-31 |
| Fidelity Management & Research Company | 12323885 | 4.07% | -1728917 | -12.30% | 2019-07-31 |
| State Street Corporation | 9929280 | 3.29% | 687957 | 7.44% | 2019-03-31 |
| Renaissance Technologies Corp | 9565273 | 3.17% | 3645546 | 61.58% | 2019-03-31 |
| State Street Global Advisors | 3481456 | 1.15% | 1300 | 0.04% | 2019-07-31 |
| SSGA Funds Management Inc | 3796209 | 1.25% | 56897 | 1.52% | 2019-07-31 |
| J.P. Morgan Investment Management, Inc. | 4728213 | 1.56% | -255130 | -5.12% | 2019-07-31 |
| T. Rowe Price Associates, Inc. | 5091189 | 1.69% | 2061388 | 68.04% | 2019-03-31 |
| First Trust Advisors L.P. | 5432435 | 1.80% | -118703 | -2.14% | 2019-03-31 |
| Fidelity Management Trust Co | 5554534 | 1.83% | -542800 | -8.90% | 2019-07-31 |
| Goldman Sachs Group Inc | 6696536 | 2.22% | 1118580 | 20.05% | 2019-03-31 |
| Vanguard Investments Australia Ltd | 8316490 | 2.75% | 72783 | 0.88% | 2019-07-31 |
| SPDR State Street Global Advisors | 3445161 | 1.14% | -78239 | -2.22% | 2019-06-30 |
| BlackRock Asset Management Canada Ltd | 35375427 | 11.72% | 6911 | 0.02% | 2019-05-31 |
| Geode Capital Management, LLC | 6018908 | 1.99% | 3219635 | 115.02% | 2018-12-31 |
| Bank of New York Mellon Corp | 3743157 | 1.24% | 643023 | 20.74% | 2018-12-31 |
| Consonance Capital Management LP | 6645113 | 2.21% | 2766063 | 71.31% | 2018-12-31 |
| JPMorgan Chase & Co | 5931216 | 1.98% | 480986 | 8.83% | 2018-09-30 |
| Matrix Capital Management Company, LLC | 10000000 | 3.33% | -- | -- | 2018-09-30 |
| Old Mutual Asset Managers UK Ltd | 4666961 | 1.55% | 995133 | 27.10% | 2018-09-30 |
| BlackRock Institutional Trust Company NA | 9230322 | 3.09% | 1163514 | 14.42% | 2018-06-30 |
| Goldman, Sachs & Co. | 4591611 | 1.54% | -1604080 | -25.89% | 2018-06-30 |
| Deutsche Bank AG | 2916702 | 0.98% | 2145603 | 278.25% | 2018-06-30 |
| State Street Global Markets, LLC | 3255362 | 1.09% | -28842 | -0.88% | 2018-07-31 |
| Jennison Associates LLC | 3194242 | 1.07% | -2035040 | -38.92% | 2018-06-30 |
| Delaware Management Business Trust | 3551314 | 1.19% | 1565490 | 78.83% | 2018-06-30 |
| Goldman Sachs Asset Management LP | 3649817 | 1.23% | -439555 | -10.75% | 2018-06-30 |
| J.P. Morgan Investment Management Inc | 4050207 | 1.36% | 250941 | 6.60% | 2018-06-30 |
| State Street Corp | 10603584 | 3.56% | 3934145 | 58.99% | 2018-06-30 |
| Wells Capital Management Inc. | 3369804 | 1.14% | 857054 | 34.11% | 2018-03-31 |
| Voya Investments, LLC | 2508845 | 0.84% | 662277 | 35.87% | 2018-06-30 |
| Invesco PowerShares Capital Mgmt LLC | 2182996 | 0.74% | -19520 | -0.89% | 2018-03-31 |
| Arrowstreet Capital Limited Partnership | 2119065 | 0.71% | 275936 | 14.97% | 2018-03-31 |
| Franklin Advisers Inc | 2134941 | 0.72% | -230330 | -9.74% | 2018-03-31 |
| NORGES BANK | 2326500 | 0.79% | 130199 | 5.93% | 2017-12-31 |
| Pictet Asset Management SA | 1907909 | 0.64% | 590278 | 44.80% | 2017-12-31 |
| Invesco Advisers, Inc | 2877387 | 0.97% | -643743 | -18.28% | 2017-12-31 |
| Two Sigma Investments LLC | 3582521 | 1.21% | -566817 | -13.66% | 2017-12-31 |
| Baker Bros Advisors LP | 2082012 | 0.70% | -- | -- | 2017-09-30 |
| D. E. Shaw & Co LP | 2073686 | 0.70% | -511757 | -19.79% | 2017-09-30 |
| Old Mutual Global Investors (UK) Limited | 2460693 | 0.86% | 1422808 | 137.09% | 2017-06-30 |
| Orbimed Advisors, LLC | 6206300 | 2.17% | 6206300 | -- | 2016-09-30 |
| Lord, Abbett & Co LLC | 5971377 | 2.09% | 3066155 | 105.54% | 2016-09-30 |
| Farallon Capital Management, L.L.C. | 5095000 | 1.78% | 180000 | 3.66% | 2016-09-30 |
| 1Globe capital LLC | 13861069 | 6.06% | 13861069 | -- | 2016-04-18 |
| Point72 Asset Management, L.P. | 4132900 | 1.44% | 2107500 | 104.05% | 2016-09-30 |
| PDT Partners, LLC | 2817464 | 0.98% | 2798586 | 14824.59% | 2016-09-30 |
| Janus Capital Management LLC | 2788674 | 0.97% | -502393 | -15.27% | 2016-09-30 |
| Northern Trust Investments N A | 2687744 | 0.94% | 126578 | 4.94% | 2016-09-30 |
| Eastern Capital LTD | 7227686 | 3.17% | -4113397 | -36.27% | 2016-02-11 |
| The Vanguard Group | 11038706 | 3.00% | 29142184 | 0.10% | 1999-11-30 |
| Eastern Capital Limited | 11341083 | 3.00% | 29940459 | 0.10% | 1999-11-30 |
| BlackRock, Inc. | 14495656 | 3.00% | 38268532 | 0.10% | 1999-11-30 |
| FMR LLC | 16537441 | 3.00% | 43658844 | 0.10% | 1999-11-30 |
| Meditor Group Ltd. | 19070213 | 3.00% | 50345362 | 0.10% | 1999-11-30 |
| 共同基金持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| iShares S&P Mid-Cap 400 Growth ETF | 1329543 | 0.44% | -- | -- | 2019-07-30 |
| iShares Core S&P Mid-Cap ETF | 8868582 | 2.93% | 17110 | 0.19% | 2019-07-30 |
| Vanguard Total Stock Market Index Fund | 8247690 | 2.72% | 72454 | 0.89% | 2019-06-30 |
| Vanguard Small Cap Index | 7716197 | 2.55% | -85366 | -1.09% | 2019-06-30 |
| Fidelity Growth Company Commingled Pool | 5554534 | 1.83% | -542800 | -8.90% | 2019-06-30 |
| First Trust NYSE Arca Biotech Fund | 4435077 | 1.46% | -10687 | -0.24% | 2019-07-31 |
| Vanguard Small Cap Growth Index Fund | 4421609 | 1.46% | -4793 | -0.11% | 2019-06-30 |
| Vanguard Extended Market Index Fund | 4149051 | 1.37% | -4229 | -0.10% | 2019-06-30 |
| iShares Nasdaq Biotechnology ETF | 2978921 | 0.98% | 30952 | 1.05% | 2019-07-30 |
| SPDR | 2866969 | 0.95% | 56221 | 2.00% | 2019-07-31 |
| JPMorgan Mid Cap Growth Fund | 1330600 | 0.44% | -192000 | -12.61% | 2019-06-30 |
| Fidelity | 1450480 | 0.48% | -- | -- | 2019-06-30 |
| State Street S&P Mid Cap Index Fund | 1840200 | 0.61% | -- | -- | 2019-06-30 |
| T. Rowe Price New Horizons Fund | 1878535 | 0.62% | 457700 | 32.21% | 2019-06-30 |
| T. Rowe Price Health Sciences Fund | 2358205 | 0.78% | 420900 | 21.73% | 2019-06-30 |
| JPMorgan Growth Advantage Fund | 2548700 | 0.84% | -- | -- | 2019-06-30 |
| BB Biotech AG | 2835000 | 0.94% | -- | -- | 2019-06-30 |
| iShares Core MSCI AllCntry Wld exCan ETF | 8746162 | 2.90% | -- | -- | 2019-05-23 |
| iShares S&P US Mid-Cap ETF (CAD-Hedged) | 8742762 | 2.90% | -- | -- | 2019-05-30 |
| iShares S&P US Mid-Cap ETF | 8742762 | 2.90% | -- | -- | 2019-05-30 |
| iShares Core S&P US Total Market ETF | 8742762 | 2.90% | -- | -- | 2019-05-30 |
| Vanguard Small Cap Index Fund | 7807565 | 2.59% | 49175 | 0.63% | 2019-04-30 |
| Merian Global Equity Absolute Return Fd | 1591503 | 0.53% | 1591503 | -- | 2018-06-30 |
| Old Mutual Global Eq Abs Ret Fund | 1591503 | 0.53% | 1591503 | -- | 2018-06-30 |
| UBS (Lux) EF Biotech (USD) | 1208584 | 0.40% | -- | -- | 2018-11-30 |
| Pictet-Biotech | 1316302 | 0.44% | 103889 | 8.57% | 2018-09-30 |
| Rhenman Healthcare Eq L/S | 1145514 | 0.38% | -215900 | -15.86% | 2018-11-30 |
| iShares S&P Mid-Cap 400 Value ETF | 1143370 | 0.38% | -- | -- | 2019-01-31 |
| Goldman Sachs Small/Mid Cap Growth Fund | 1295449 | 0.43% | 199639 | 18.22% | 2018-09-30 |
| Invesco DWA Momentum ETF | 1467478 | 0.49% | -- | -- | 2018-03-31 |
| American Century Growth Fund | 1607807 | 0.54% | 320769 | 24.92% | 2018-09-30 |
| Voya MidCap Opportunities Port | 1456074 | 0.49% | 394906 | 37.21% | 2018-06-30 |
| Delaware Smid Cap Growth Fund | 1364700 | 0.46% | -629675 | -31.57% | 2018-09-30 |
| Delaware Smid Cap Growth A | 3387400 | 1.14% | 186125 | 5.81% | 2018-07-31 |
| T. Rowe Price Health Sciences | 1131638 | 0.38% | -1822119 | -61.69% | 2018-06-30 |
| Fidelity Spartan | 1273671 | 0.43% | 17019 | 1.35% | 2018-07-31 |
| Vanguard Total Stock Mkt Idx | 7466804 | 2.51% | 6900 | 0.09% | 2018-07-31 |
| Vanguard Small Cap Growth Index Inv | 4264522 | 1.43% | 63201 | 1.50% | 2018-07-31 |
| Vanguard Extended Market Idx Inv | 3739805 | 1.25% | 41363 | 1.12% | 2018-07-31 |
| First Trust NYSE Arca Biotech ETF | 3489737 | 1.04% | -- | -- | 2018-09-13 |
| iShares Nasdaq Biotechnology | 3366639 | 1.00% | -6408 | -0.19% | 2018-09-12 |
| iShares S&P Mid-Cap 400 Growth | 2532147 | 0.76% | 25032 | 1.00% | 2018-09-12 |
| Voya MidCap Opportunities Port I | 1456074 | 0.49% | 394906 | 37.21% | 2018-06-30 |
| Prudential Jennison Health Sciences A | 1447527 | 0.49% | -- | -- | 2018-07-31 |
| JPMorgan Growth Advantage A | 1377100 | 0.46% | 9900 | 0.72% | 2018-07-31 |
| American Century Growth Inv | 1287038 | 0.43% | 1287038 | -- | 2018-06-30 |
| Goldman Sachs Small/Mid Cap Growth A | 1095810 | 0.37% | -- | -- | 2018-06-30 |
| T. Rowe Price New Horizons | 2475201 | 0.83% | 563900 | 29.50% | 2018-03-31 |
| State Street Russell Small/Mid Cap Idx Fd Cl I | 946587 | 0.32% | 207000 | 27.99% | 2017-06-30 |
| Prudential Jennison Mid Cap Growth A | 1228525 | 0.41% | -15425 | -1.24% | 2018-04-30 |
| Vanguard Strategic Equity Inv | 903312 | 0.30% | 55280 | 6.52% | 2017-12-31 |
| Vanguard Explorer Inv | 1087458 | 0.37% | 308596 | 39.62% | 2017-12-31 |
| Invesco Small Cap Growth A | 1182037 | 0.40% | -- | -- | 2017-12-31 |
| T. Rowe Price Small-Cap Stock | 1041200 | 0.35% | -6300 | -0.60% | 2017-12-31 |
| PowerShares DWA Momentum ETF | 1467478 | 0.43% | 134461 | 10.09% | 2018-03-29 |
| Fidelity Advisor | 1058049 | 0.36% | -59400 | -5.32% | 2018-01-31 |
| CREF Stock R1 | 957502 | 0.32% | -12127 | -1.25% | 2017-12-31 |
| iShares Russell 1000 Growth | 896346 | 0.30% | -1510 | -0.17% | 2018-01-10 |
| Lord Abbett Developing Growth A | 2233207 | 0.78% | -707173 | -24.05% | 2016-12-31 |
| iShares Russell 2000 Growth | 1142769 | 0.45% | -- | -- | 2017-02-07 |
| Janus Global Life Sciences D | 1142530 | 0.40% | -536506 | -31.95% | 2016-12-31 |
| Fidelity® Select Biotechnology Portfolio | 5125140 | 2.30% | -- | -- | 2015-09-30 |
| Fidelity® Series Growth Company Fund | 4030464 | 1.80% | 900 | -- | 2015-09-30 |
| SPDR® S&P Biotech ETF | 4018791 | 1.60% | 26168 | 0.70% | 2015-11-19 |
| iShares Russell 2000 (AU) | 3574411 | 1.50% | -4506 | -0.10% | 2015-11-19 |
| Fidelity® Blue Chip Growth Fund | 2828200 | 1.20% | -- | -- | 2015-09-30 |
| T. Rowe Price Small-Cap Stock Fund | 2706300 | 1.20% | 837700 | 44.80% | 2015-09-30 |
| Invesco Small Cap Growth Fund | 2038036 | 0.90% | 2038036 | -- | 2015-09-30 |
| Fidelity® Growth Company Fund | 14421365 | 6.40% | -155082 | -1.10% | 2015-09-30 |
abu_quant
扫一扫关注阿布量化
热门推荐
全部评论 0
暂无评论